Drug Type Drug conjugates |
Synonyms- |
Target |
Action inhibitors, modulators |
Mechanism CD22 inhibitors(CD22 inhibitors), Ribonuclease modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 11 Jul 2006 |